Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis).

Dermatol Ther (Heidelb) · 2026 · PMC13046912 · PMID 41840326

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

Although these differences did not reach statistical significance (all p > 0.05), the observed trend suggests that baseline scalp involvement did not negatively impact early global skin response to deucravacitinib and may even be associated with a numerically more favorable overall clinical response in this real-world cohort.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.